• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Screening of signal transducing molecules by using transient expression

Research Project

Project/Area Number 10557038
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Immunology
Research InstitutionKurume University

Principal Investigator

YOSHIMURA Akihiko  Institute of Life Science, Kurume University, Professor, 分子生命科学研究所, 教授 (90182815)

Co-Investigator(Kenkyū-buntansha) YASUKAWA Hideo  Institute of Life Science, Kurume University, Assistant Professor, 分子生命科学研究所, 助手 (60289361)
OHTSUBO Motoaki  Institute of Life Science, Kurume University, Assistant Professor, 分子生命科学研究所, 助手 (10211799)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥12,300,000 (Direct Cost: ¥12,300,000)
Fiscal Year 1999: ¥3,900,000 (Direct Cost: ¥3,900,000)
Fiscal Year 1998: ¥8,400,000 (Direct Cost: ¥8,400,000)
Keywordstyrosine kinase / JAK / STAT / CIS / cytokine / knockout mice / tyrosine phosphorylation / interferon / SH2ドメイン / シグナル伝達 / APS
Research Abstract

To identify the novel substrate of tyrosine kinases which is important for proliferation or differentiation, we developed a two-hybrid screening using active c-kit as bait. We cloned new adaptor molecules, APS and STAP-1 which contain SH2 domain and PH domain. RT-POR analysis revealed that STAP-1 expression is restricted in bone marrow cell fraction expressing c-kit, and the highest expression was observed in CD34-Sca-1+c-Kit+Lin- hematopoietic stem cell enriched fraction. Murine myeloid cell line, M1 expressed high level of STAP-1. However, the expression was strongly repressed in response to leukemia inhibitory factor which induced monocytic differentiation of M1 cells, suggesting that STAP-1 is associated with undifferentiated cell type. In 293 cells, STAP-1 was tyrosine phosphorylated by activated c-kit. In vitro binding assay suggested that STAP-1 SH2 domain interacted with several tyrosine phosphorylated protein including c-kit and STAT5. These suggest that STAP-1 function as a a … More daptor molecule downstream of c-kit in hematopoietic stem cells.
Furthermore, we recently cloned a novel substrate of c-kit or other tyrosine kinases. This gene, we call WARS, does not contain any SH2 or PH domain but has a novel domain related to a gene that is a negative regulator of Ras-MAP kinase in Drosophila. We will try to find the function of this gene in development of cancer.
We cloned a novel SH2 protein JAB, that binds to the kinase domain of JAK2. JAB interacts with and inhibits JAK tyrosine kinases. Through the SH2 domain, JAB binds to a phosphotyrosine in the activation loop of the JAK kinases and suppresses their catalytic activity. We have shown that JAB is strongly induced by interferon-γ. We demonstrate that JAB deficient mice die perinatally with altered lymphoid development including the generation of activated T cells in vivo. The lethality is eliminated on a Rag2 or interferon-γ. Deficient background . Based on the results, we propose that JAB plays an essential role in negative feedback regulation of interferon-γ. Less

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Marine JC, et al.: "SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality"Cell. 98・5. 609-616 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Marine JC, et al.: "SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis"Cell. 98・5. 617-627 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsumoto A, et al.: "Suppression of STAT5 Functions in Liver, Mammary Glands, and T. Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice"Mol. Cell. Biol.. 19・9. 6396-6407 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sasaki A, et al.: "Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain"Genes to Cells. 4・6. 339-351 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yasukawa H, et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop"EMBO J.. 18・5. 1309-1320 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yokouchi M, et al.: "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl, and inhibits PDGF-induced mitogenesis"Oncogene. 18・3. 759-767 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Marine JC, et al: "SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis."Cell 98. 5. 617-627 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Marine JC, et al: "SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality."Cell 98. 5. 609-616 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsumoto A, et al: "Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice."Mol. Cell. Biol.. 19, 9. 6396-6407 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sasaki A, et al: "Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain."Genes to Cells. 4, 6. 339-351 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yasukawa H, et al: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop."EMBO J.. 18, 5. 1309-1320 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yokouchi M, et al: "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cb1, and inhibits PDGF-induced mitogenesis."Oncogene. 18, 3. 759-767 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Marine JC,et al.: "SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality."Cell. 98・5. 609-616 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Marine JC,et al.: "SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis."Cell. 98・5. 617-627 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Matsumoto A,et al.: "Suppression of STAT5 Functions in Liver,Mammary Glands,and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice."Mol.Cell.Biol.. 19・9. 6396-6407 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sasaki A,et al.: "Cytokine-inducible SH2 protein-3 (CIS3/SOCS3)inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain."Genes to Cells. 4・6. 339-351 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yasukawa H,et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop."EMBO J.. 18・5. 1309-1320 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yokouchi M,et al.: "APS,an adaptor protein containing PH and SH2 domains,is associated with the PDGF receptor and c-Cb1,and inhibits PDGF-induced mitogenesis"Oncogene. 18・3. 759-767 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yasukawa H,et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop." EMBO J.18,5. 1309-1320 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Wakioka T,et al.: "APS an Adaptor Protein Containing PH and SH2 Domains Inhibits the JAK-STAT Pathway in Collaboration with c-Chl" Leukemia. in press. (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yokouchi M.et al.: "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF induced mitogenesis." Oncogene. 18,3. 759-767 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tanimura S,et al.: "MDM2 interacts with MDMX through their RING finger domains." FEBS Lett.in press. (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Sakamoto H,et al.: "A Janus kinase inhibitor,JAB, is an interferon-γ-inducible gene and confers resistance to interferons." Blood. 92,5. 1668-1676 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Misawa H,et al.: "Cloning and characterization of a novel class II phsophoinositide 3-kinase containing C2 domain." Biochem.Biophys.Res.Commun.244,2. 531-539 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi